The disparities between these studies may arise from chemotaxis in living cells (Figure 1) . Initial studies on G incomplete pharmacological inhibition, the presence of protein coupled chemoattractant receptors in D. dismultiple PI 3-kinase isoforms, compensatory mechacoideum and subsequent studies in human neutrophils nisms, or nonlinear relationships between different comshow that these receptors remain uniformly distributed ponents in the pathway. Additional studies are necesaround the plasma membrane during chemotaxis. Likesary to resolve these discrepancies and to define the wise, G protein ␤␥ subunits do not cluster at the front precise functions of PI 3-kinases during eukaryotic cheof chemotaxing cells, but localize in a shallow anterior motaxis. to posterior gradient that approximates receptor occuOriginally identified as a tumor suppressor gene mupancy (Jin et al., 2000) . Studies on the PH domains tated in a large percentage of human cancers, the PI(3,4,5)P 3 / PI(3,4)P 2 degrading enzyme, PTEN (Phosphatase and Tensin homolog), has emerged as a key 3 Correspondence: parentc@helix.nih.gov
. P-Rex1 is laboratory constitutively targeted PI 3-kinases to the subject to synergistic activation by both PI(3,4,5)P 3 and plasma membrane, they observed defects that pheno-G protein ␤␥ subunits, suggesting a role in signal integracopy the pten Ϫ cells. The fact that loss of PTEN or loss tion between these two pathways. Such a GEF and its of spatial restriction of PI 3-kinase result in similar phenotypes implies that the localized production and reassociated GTP binding protein may be a nexus be-
